|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antiangiogenesis therapeutic strategies and clinical application for brain tumors显示文摘 | Puduvalli VK Sawaga R | 2000 | J Neurooncol2000，50，12： | 1 |
| 2 | Biomarkers of disease : eerebrospinal fluid vascular endothelial growth factor(VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis(NM) due to breast cancer,lung cancer and melanoma 显示文摘 | Groves MD Hess KR Puduvalli VK | 2009 | J Neurooncol2009，94，2： | 1 |
| 3 | Pallerns of expression of Rb and pl6 in astrocytic gliomas, and corre- lation with survival显示文摘 | Puduvalli VK Kyrilsisf AP Hess KR | 2000 | Int J Oncol2000，17，5： | 1 |
| 4 | Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation显示文摘 | Sampath D Calin GA Puduvalli VK | 2009 | Blood2009，113，16： | 1 |
| 5 | Antiangiogenesis therapeutic strategiesand clinical implications for brain tumors 显示文摘 | Puduvalli V K Sawaya R | 2000 | J Neurooncol2000，50，12： | 1 |
| 6 | Antiangiogenesis-therapeutic strategies and clinical implications for brain tumors显示文摘 | Puduvalli Raymond | 2000 | J Neurooncol2000，50，： | 1 |
| 7 | Phase Ⅱ trial of temozolomide plus the matrix metalloproteinase inhibitor, ma rimastat, in recurrent and progressive glioblastoma multiforme 显示文摘 | Groves MD Puduvalli VK Hess KR | 2002 | J Clin Oncol2002，20，5： | 1 |
| 8 | Combination chemo- therapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme 显示文摘 | Levin VA Giglio P Puduvalli VK | 2006 | J Neurooncol2006，78，1： | 1 |
| 9 | Antiangiogenesis therapeutic stragegies and clinical implications for brain tumors 显示文摘 | Puduvalli VK Sawaga R | 2000 | J Neurooncol2000，50，12： | 1 |
| 10 | Phase Ⅱ trial of temozolomide plus the matrix metallopmteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme显示文摘 | Groves MD Puduvalli VK Hess KR | 2002 | J Clin Oncol2002，20，5： | 1 |
| 11 | Phase Ⅱ trial of temozolomide plus the matrixmetalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastom a multiforme显示文摘 | Groves M D Puduvalli V K Hess K R | 2002 | J ClinOncol2002，20，： | 1 |
| 12 | Phase Ⅰ trail of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma:a North American Brain Tumor Consortium Study显示文摘 | Groves MD Puduvalli VK Hess KR | 2003 | J Clin Oncol2003，97，： | 1 |
| 13 | Antiangiogenesis herapeutic strategies and clinical implications for brain tumors 显示文摘 | Puduvalli VK Sawaya R | 2000 | J Neuro-oncol2000，50，12： | 1 |
| 14 | Fenrctinide activates Caspases and induces apoptosis in gliomas显示文摘 | Puduvalli VK Saito Y Xu R | 1999 | Clin Cancer Res1999，5，8： | 1 |
| 15 | Phase Ⅱ trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme显示文摘 | Puduvalli VK Giglio P Groves MD | 2008 | Neuro-Oncology2008，10，2： | 1 |
| 16 | Biomarkers of dis- ease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF) -1 levels in pa- tients with neoplastic meningitis (NM) due to breast Cancer, lung Cancer and melanoma 显示文摘 | Groves MD Hess KR Puduvalli VK | 2009 | J Neurooncol2009，94，2： | 1 |
| 17 | Phase Ⅱ study of fenretinide (NSC 37455 1)in adults with recurrent malignant gliomas:A North American Brain Tumor Consortium Study显示文摘 | Vinav K Gabriela V Puduvalli WK | 2004 | Clin Oncol2004，11，22： | 1 |
| 18 | Inhibition of angiogenesis as a therapeutic strategy against brain tumors显示文摘 | Puduvalli VK | | 0，，： | 1 |
| 19 | Phase istudy of vori-nostat in patients with high-grade gliomas:North American brain tumor consortium study 04-03显示文摘 | Lee EQ Puduvalli VK Reid JM | 2013 | Clin Cancer Res2013，18，21： | 1 |
| 20 | Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme 显示文摘 | Groves M D Puduvalli V K Hess K R | 2002 | J Clin Oncol2002，20，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员